US warns 5 Indian firms selling unapproved drugs, Covid ‘cures’
AUGUST 14, 2020 1:25:07 PM
The FDA inspection found several other discrepancies in the laboratory testing and other practices at Windlas Healthcare, such as failure to establish an adequate quality control unit.
.png)
No hay comentarios:
Publicar un comentario